In 2019, genetically modified drugs were the leading produced good within the South Korean biopharmaceutical industry, with a production value of around 1.02 trillion South Korean won. Other commonly produced items included plasma fractionation agents as well as vaccines.
Value of biopharmaceuticals produced in South Korea in 2019, by type of product (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Immunoglobulin utilization growth 2015-2017, by diagnosis
- Premium Statistic Immunoglobulin consumption in select countries 2017
- Premium Statistic Value added of pharmaceutical companies in Italy 2016-2018
- Basic Statistic Top countries in global blood plasma market in 2017, by value
- Basic Statistic Global blood plasma market share 2017, by country
- Basic Statistic Per capita albumin consumption change 2012-2016, by country
- Premium Statistic Mexico: pharmaceutical expenditure 2012-2018
- Premium Statistic Market value of prescription drugs in Italy 2001-2022
- Premium Statistic Sales volume of the pharmaceutical market in Italy 2014-2022, by product
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
About the region
10
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic R&D investment Beijing Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
Selected statistics
6
- Premium Statistic Pfizer's ad spending 2006-2023
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
Other regions
10
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
- Basic Statistic Employment at select top pharmaceutical companies in Denmark 2022
- Premium Statistic Widest CEO-employee pay gap among biopharmaceutical firms 2019
- Basic Statistic Leading pharmaceutical companies in Norway 2021, by revenue
- Premium Statistic Pharmaceuticals production value in Colombia 2014-2020
- Premium Statistic Mexico: public medicine expenditure 2012-2018, by supplier
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2022
- Basic Statistic Alaska's medical cannabis spending 2018-2024
Related statistics
10
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2022
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
Further related statistics
10
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- GSK's operating profit by division 2006-2021
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co total assets 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Further Content: You might find this interesting as well
Statistics
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- GSK's operating profit by division 2006-2021
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co total assets 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
KHIDI. (October 22, 2021). Value of biopharmaceuticals produced in South Korea in 2019, by type of product (in billion South Korean won) [Graph]. In Statista. Retrieved April 25, 2024, from https://www.statista.com/statistics/1297073/south-korea-biopharma-production-value-by-product-type/
KHIDI. "Value of biopharmaceuticals produced in South Korea in 2019, by type of product (in billion South Korean won)." Chart. October 22, 2021. Statista. Accessed April 25, 2024. https://www.statista.com/statistics/1297073/south-korea-biopharma-production-value-by-product-type/
KHIDI. (2021). Value of biopharmaceuticals produced in South Korea in 2019, by type of product (in billion South Korean won). Statista. Statista Inc.. Accessed: April 25, 2024. https://www.statista.com/statistics/1297073/south-korea-biopharma-production-value-by-product-type/
KHIDI. "Value of Biopharmaceuticals Produced in South Korea in 2019, by Type of Product (in Billion South Korean Won)." Statista, Statista Inc., 22 Oct 2021, https://www.statista.com/statistics/1297073/south-korea-biopharma-production-value-by-product-type/
KHIDI, Value of biopharmaceuticals produced in South Korea in 2019, by type of product (in billion South Korean won) Statista, https://www.statista.com/statistics/1297073/south-korea-biopharma-production-value-by-product-type/ (last visited April 25, 2024)
Value of biopharmaceuticals produced in South Korea in 2019, by type of product (in billion South Korean won) [Graph], KHIDI, October 22, 2021. [Online]. Available: https://www.statista.com/statistics/1297073/south-korea-biopharma-production-value-by-product-type/